Live website intelligence
iPLEDGE REMS - Home
The iPLEDGE PROGRAM REMS (Risk Evaluation and Mitigation Strategy) The iPLEDGE PROGRAM REMS is a safety program to manage the risk of isotretinoin’s teratogenicity and to minimize fetal exposure. The REMS is required by the U.S. Food and Drug Administration (FDA) to ensure the benefits of isotretinoin outweigh its risks.
Last refresh
Updated 20h ago
Analyst read
Professional
Detected stack
Quick read
How to read ipledgeprogram.com quickly
ipledgeprogram.com looks like health & fitness. Traffic estimates are limited, so use the trust and structure modules first. Current AI trust scoring is 12/100.
What to do next
- The stack appears to include Unknown.
- Open the Traffic tab if you need audience scale and geography before outreach.
- Open the Business tab if trust, monetization, or positioning is your first decision filter.
Provider Completeness
41/56 fields populated (73%)
Providers with missing fields
View field-level status
visual: 3/4
Missing: screenshotUrl
meta: 3/3
All expected fields present
seo: 5/5
All expected fields present
dns: 4/4
All expected fields present
ads: 5/5
All expected fields present
publisher: 5/5
All expected fields present
files: 3/3
All expected fields present
traffic: 0/10
Missing: monthlyVisits, globalRank, countryRank, bounceRate, avgVisitDuration, pagesPerVisit, topCountry, topRegions, topKeywords, trafficSources
whois: 6/6
All expected fields present
radar: 0/4
Missing: globalRank, rankBucket, categories, sourceTimestamp
ai: 7/7
All expected fields present
Why this module matters
Business signals help answer “is this a real opportunity?”
Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.
- Trust score and sentiment are your first risk screen.
- Business summary and audience notes speed up qualification.
- Ads and monetization patterns reveal how the site captures value.
Business Intelligence
Business Profile
iPLEDGE REMS is an FDA-mandated drug safety and compliance program focused on controlling isotretinoin prescribing and monitoring to prevent fetal exposure and manage teratogenic risk.
Classification
Trust & Risk
Trust Assessment
Google Ads Transparency
Publisher Monetization
Monetization Signals
AI Visual Analysis
IAB Taxonomy
Business Insights
Business Model
Regulatory Compliance Program model detected
Trust Level
Low trust with 12/100 score
Audience
Healthcare providers, pharmacists, patients using isotretinoin, and healthcare administrators involved in REMS compliance
Keep exploring
Keep exploring from this report
Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.